Lacosamide in Painful Diabetic Neuropathy: An 18-Week Double-Blind Placebo-Controlled Trial
To access this article, please choose from the options below
Supported in part by SCHWARZ BIOSCIENCES, GmbH, UCB Group, Monheim, Germany, which provided the trial supplies, and SCHWARZ BIOSCIENCES, Inc., UCB Group, Research Triangle Park, North Carolina, which sponsored and funded the trial.
PII: S1526-5900(09)00310-1
doi:10.1016/j.jpain.2009.01.322
© 2009 American Pain Society. Published by Elsevier Inc. All rights reserved.
